Zydus Lifesciences received USFDA's Establishment Inspection Report and approval letter for its SEZ oncology injectable manufacturing facility in Ahmedabad.
The Pre-Approval Inspection was conducted from November 4th to 13th, 2025, for a new isolator injectable line.
This disclosure is made pursuant to Regulation 30 of SEBI Listing Regulations.